Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Yifeng Liu
Yifeng Liu
Stock Analyst at HSBC
(n/a)
# 4,425
Out of 4,433 analysts
3
Total ratings
n/a
Success rate
-36.03%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
2 Stocks
Stock
Action
Price Target
Current
Upside
Ratings
Updated
MRNA
Moderna
Downgrades:
Reduce
$75
→
$86
$132.68
-35.18%
2
Feb 26, 2024
BNTX
BioNTech SE
Downgrades:
Hold
$124
→
$111
$92.98
+19.38%
1
Oct 16, 2023
MRNA
Moderna
Feb 26, 2024
Downgrades:
Reduce
Price Target:
$75
→
$86
Current: $132.68
Upside:
-35.18%
2 Ratings
View All
BNTX
BioNTech SE
Oct 16, 2023
Downgrades:
Hold
Price Target:
$124
→
$111
Current: $92.98
Upside:
+19.38%
1 Ratings
View All